Arkolith/Insider Trading/TLSI/Form 4

Cox Bryan F.

Chief of ResearchTriSalus Life Sciences, Inc. (TLSI) · full profile →Form 4 · filed May 21, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$25K
Net Open-Market Flow
-$25K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 19, 2025Grant(A)16K$5.18$81K124K
May 19, 2025Sell(S)5K$5.18$25K119K

Transaction Codes

A
Grant / award
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001826667-25-000061) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML